These new reports will definitely incorporate a sense of relief in women diagnosed with breast cancer or struggling with the condition. It has been reported that even after being operated for cancer, women live with fear that tumor will return.
Hence, most of them are suggested to undergo chemotherapy for yet other six-months so as to decrease the chances of retrieval of the cancer. These chemotherapy sessions are devastating and cause major changes in body, including hair loss and in some cases, even fertility.
However, this recent research by a team of researchers at Breakthrough Breast Cancer Research Centre at The Institute of Cancer Research and The Royal Marsden NHS, UK, have subjected that they have discovered a test that can help predict, whether the cancer will revert or not, even after it has been surgically removed.
It has been termed that this test ICH4 will be able to administer the low-risk tumors and thus, avoid women from undergoing chemotherapy. It has been revealed that this test will take into consideration levels of ER, PR, HER2 and Ki67 proteins in the tumor.
Moreover, it has been termed that test is simple and cost-effective. Hence, it will reduce the burden on NHS also.
Latest reports suggest that it is being examined by National Institute for Health and Clinical Excellence (NICE).
pietrus cheney tori spelling marion barber marion barber syracuse ohio state
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.